DHRDanaher Corporation
Is it growing?
Growing: earnings up +26% year on year and operating margin widening (+1.4 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −2% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 20.4% now against 19.0% a year earlier.
All from SEC EDGAR, as of Sep 25, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is DHR growing?
Danaher Corporation's revenue has grown 1.3% a year over three years, and shrunk 1.8% a year over five, with earnings per share falling 8.3% a year.
Revenue growth, 3-year annual rate · Diagnostics & Research median +8.6% · growing slowly · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- −1.8%
Revenue growth, 5-year rate · +1.3% over three · growth has picked up over the last three years
- Earnings per share, 3-year rate
- −8.3%
Earnings per share, 3-year rate · revenue +1.3% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $24.8B
- Revenue FY2022
- $26.6B
- Revenue FY2023
- $23.9B
- Revenue FY2024
- $23.9B
- Revenue FY2025
- $24.6B
Annual income statements as filed with the SEC.
Diagnostics & Research
The closest names by size in the same industry